0.00Open19.50Pre Close0 Volume2 Open Interest50.00Strike Price0.00Turnover8992.26%IV2.89%PremiumMay 2, 2025Expiry Date17.55Intrinsic Value100Multiplier-5DDays to Expiry1.95Extrinsic Value100Contract SizeAmericanOptions Type0.9708Delta0.0053Gamma3.46Leverage Ratio-265.9388Theta0.0000Rho3.36Eff Leverage0.0001Vega
Novo-Nordisk A/S Stock Discussion
Sales increased by 19% in Danish kroner and 18% at constant exchange rates to reach 78.1 billion kroner in the first three months of 2025. Sales from international operations increased by 18% in Danish kroner (19% at constant exchange rates).
Diabetes and obesity sales increased 21% in Danish kroner to 73.5 billion kroner (19% at CER). The ...
Gapping Up
$Disney (DIS.US)$ jumped 8.3% after the company reported fiscal second-quarter adjusted earnings of $1.45 a share, surpassing Wall Street's estimates of $1.19, and projected a fiscal 2025 adjusted profit of $5.75 per share, which is higher than the consensus estimate of $5.43. Additionally, Disney consented to collaborate with Miral on the construction of a theme park and resort in Abu Dhabi.
$Novo-Nordisk A/S (NVO.US)$'s stock c...
• Aussie markets...to benefit from gold rising to its second highest level in histor...
Earnings more than quadrupled to 22 cents a share in the three months ended March 31, surpassing estimates by 68%, according to Bloo...
Hims & Hers Health reported exceptional Q1 2025 financial results with revenue soaring 111% to $586.0 million, compared to $278.2 million in Q1 2024. Online revenue grew 115% to $576.4 million, primarily driven by weight loss solutions including GLP-1 offerings which generated approximately $230 million. The company achieved net income of $49.5 million and Adjusted EBITDA of $91.1 million, with gross margin at 73%.
$Novo-Nordisk A/S (NVO.US)$
No comment yet